Create Account
D
AREV Life Sciences Global Corp.
AREV
CNSX
Recommendation
Sell
Prev Close
$0.185
Avg Vol (90D)
10,721
Market Cap
$4.38M
Dividend & Yield
--
52-Week Range
$0.10 - $0.39
P/E (TTM)
--
EPS (TTM)
-$0.0569
My Lists My Alerts
Rating
Reward
C-
Fair
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
--
Solvency Index
Weak
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$202.50K
EBITDA (TTM)
-$1.37M
EBIT (TTM)
-$1.49M
Net Income (TTM)
-$790.00K
Balance Sheet
Total Assets (Q)
$492.00K
Total Debt (Q)
$59.90K
Total Liabilities (Q)
$565.90K
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
-$1.18M
Cash from Investing (TTM)
$35.60K
Cash from Financing (TTM)
$1.02M
Net Change in Cash (TTM)
-$125.00K
Filings
Filing Date
Monday, May 2, 2022
Period Date
Friday, December 31, 2021
Next Filing
Week of Aug 22 and 26 (est)
Price History
Loading...
Beta
0.86
7-Day Total Return
2.44%
30-Day Total Return
-4.55%
60-Day Total Return
-20.75%
90-Day Total Return
-46.15%
Year to Date Total Return
-32.26%
1-Year Total Return
27.27%
2-Year Total Return
50.00%
3-Year Total Return
-87.50%
5-Year Total Return
-87.50%
52-week Low
Nov 08, 2021 - $0.10
52-week High
Jan 19, 2022 - $0.39
Valuation
Market Cap
$4.38M - Nano Cap
Enterprise Value
$4.42M
Price/Sales (TTM)
23.42
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
25.43M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arevlifesciences.com
Phone Number
604 803 8439
Address
18 - 91 Golden Drive
Coquitlam, BC V3K 6R2
Country
Canada
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company’s CBD-infused products, include Canna-Mulsion and... more
Weiss Ratings